Xiaoming Fei

569 total citations
25 papers, 100 citations indexed

About

Xiaoming Fei is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaoming Fei has authored 25 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Xiaoming Fei's work include Multiple Myeloma Research and Treatments (5 papers), Mesenchymal stem cell research (4 papers) and Bone and Joint Diseases (3 papers). Xiaoming Fei is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Mesenchymal stem cell research (4 papers) and Bone and Joint Diseases (3 papers). Xiaoming Fei collaborates with scholars based in China and United States. Xiaoming Fei's co-authors include Li Zhang, Houli Liu, Jian Wang, Lixia Wang, Xiaofeng Shi, Wenjuan Zheng, Liang Ma, Wei Ye, Shudong Hu and Junxia Li and has published in prestigious journals such as Blood, IEEE Transactions on Power Systems and International Journal of Heat and Mass Transfer.

In The Last Decade

Xiaoming Fei

21 papers receiving 97 citations

Peers

Xiaoming Fei
Comparison fields: 5 of 58
  • Mechanical Engineering 36
  • Computational Mechanics 22
  • Hematology 17
  • Genetics 13
  • Molecular Biology 12
Replace Junjun Ma with:
Junjun Ma China
Jingcheng Xie China
Zhen Qian China
Kahia Messaoudi France
Fei Dong China
Michael Heider Germany
S. Schmitz Germany
Ali H. Dhanaliwala United States
Yanbin Xu China
Xiangjie Niu China
Junjun Ma China View profile →
Citations per field, relative to Xiaoming Fei
Xiaoming Fei · 1×
Citations per year, relative to Xiaoming Fei
Xiaoming Fei · 1×

Countries citing papers authored by Xiaoming Fei

Since Specialization
Citations

This map shows the geographic impact of Xiaoming Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Fei more than expected).

Fields of papers citing papers by Xiaoming Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Fei. The network helps show where Xiaoming Fei may publish in the future.

Co-authorship network of co-authors of Xiaoming Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Fei. A scholar is included among the top collaborators of Xiaoming Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Fei. Xiaoming Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 0
3 1
4 0
5 7
6 1
7 7
8 6
9 31
10 6
11 4
12 1
13 10
14
In vitro migratory aberrancies of mesenchymal stem cells derived from multiple myeloma patients only partially modulated by bortezomib.
2
15
[Chemotaxis-related factors are expressed abnormally in bone marrow mesenchymal stem cells of multiple myeloma patients].
0
16 1
17 8
18
[Human bone marrow stromal cells facilitate the cord blood CD34+ cells ex vivo expansion and short-term engraftment in NOD/SCID mice].
3
19
[Effect of co-culture of bone marrow mesenchymal stem cells and K562 cells on expression of interleukin 8].
3
20
[Effects of As2O3, dexamethasone and thalidomide on apoptosis and cytoplasmic [Ca2+] of myeloma cell line U266].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026